Generic Name and Formulations:
Succimer 100mg; caps.
Recordati Rare Diseases, Inc.
Indications for CHEMET:
Lead poisoning in children with blood lead levels >45micrograms/dL.
May swallow caps whole or put contents onto a small amount of soft food or a spoon and swallow, followed by fruit drink. <12months: not recommended. ≥12months: initially 10mg/kg (or 350mg/m2) every 8 hours for 5 days, then reduce frequency to every 12 hours for 14 more days. Allow at least 14 days between courses unless blood lead levels indicate need for more prompt treatment. Treatment for more than 3 consecutive weeks: not recommended.
Monitor for rebound elevated lead levels by measuring blood levels at least once weekly. Maintain adequate hydration. Monitor renal and hepatic function. Monitor for neutropenia; instruct patients to report any sign of infection or rash. Renal impairment. History of hepatic dysfunction. Find and remove source of lead from environment. Pregnancy (Cat.C). Nursing mothers: not recommended.
Other concomitant chelation therapy (e.g., EDTA): not recommended. False (+) results with nitroprusside test (e.g., Ketostix).
GI upset, elevated serum transaminases, rash, pain, cramps, flu-like symptoms, dizziness, drowsiness, paresthesia; neutropenia, mucocutaneous vesicular eruptions (rare).
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|